UB Paderborn / Katalog / Suche / in CDI

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15701

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of two types of exercise training on psychological well‐being, sleep, quality of life and physical fitness in patients with high‐grade glioma (WHO III and IV): study protocol for a randomized controlled trial

Cancer communications (London, England), 2019-08, Vol.39 (1), p.1-10

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted Radiolabeled Compounds in Glioma Therapy

Seminars in nuclear medicine, 2016-05, Vol.46 (3), p.243-249

2016

Link zum Volltext

Verfügbarkeit prüfen

High Precision Bone Cutting by Er: YAG Lasers Might Minimize the Invasiveness of Navigated Brain Biopsies

Frontiers in oncology, 2022-01, Vol.11, p.690374-690374

2022

Link zum Volltext

Verfügbarkeit prüfen

Training of Denoising Diffusion Models for Prediction of real-time Growth of Primary and Recurrent Gliomas

Brain & spine, 2023, Vol.3, p.102171, Article 102171

2023

Link zum Volltext

Verfügbarkeit prüfen

Among Persons With Multiple Sclerosis (MS), Objective Sleep, Psychological Functioning, and Higher Physical Activity Scores Remained Stable Over 2 Years-Results From a Small Study Under Naturalistic Conditions

Frontiers in psychiatry, 2020-12, Vol.11, p.586244

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between IL-8 (-251T/A) and IL-6 (-174G/C) Polymorphisms and Oral Cancer Susceptibility: A Systematic Review and Meta-Analysis

Medicina (Kaunas, Lithuania), 2021-04, Vol.57 (5), p.405

2021

Link zum Volltext

Verfügbarkeit prüfen

90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

The Journal of nuclear medicine (1978), 2015-11, Vol.56 (11), p.1748-1751

2015

Link zum Volltext

Verfügbarkeit prüfen

Local Targeting of Malignant Gliomas by the Diffusible Peptidic Vector 1,4,7,10-Tetraazacyclododecane-1-Glutaric Acid-4,7,10-Triacetic Acid-Substance P

Clinical cancer research, 2006-06, Vol.12 (12), p.3843-3850

2006

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results of Targeted Low-Grade Glioma Treatment with 213 Bi-DOTA-[Thi 8 ,Met(O 2 ) 11 ]-Substance P

Cancer biotherapy & radiopharmaceuticals, 2019-08, Vol.34 (6), p.413

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive neural stem cells become invasive in vitro by combinatorial FGF2 and BMP4 signaling

Journal of cell science, 2013-01

2013

Link zum Volltext

Verfügbarkeit prüfen

An Unusual Bump on the Head: Intracranial and Extracranial Cytokeratin-Positive Interstitial Reticular Cell Tumor

World neurosurgery, 2020-07, Vol.139, p.60-62

2020

Link zum Volltext

Verfügbarkeit prüfen

Effects of two types of exercise training on psychological well-being, sleep and physical fitness in patients with high-grade glioma (WHO III and IV)

Journal of psychiatric research, 2022-07, Vol.151, p.354-364

2022

Link zum Volltext

Verfügbarkeit prüfen

Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study

The Journal of nuclear medicine (1978), 2024-04, Vol.65 (4), p.573

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Tumor Control Following Targeted Alpha Therapy : A New Treatment Paradigm?

International journal of molecular sciences, 2023-10, Vol.24 (21)

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia

The Lancet (British edition), 2024-02, Vol.403 (10425), p.469-470

2024

Link zum Volltext

Verfügbarkeit prüfen

Anti-GABA A receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia

The Lancet (British edition), 2024-02, Vol.403 (10425), p.469

2024

Link zum Volltext

Verfügbarkeit prüfen

A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers

Journal of neuro-oncology, 2015-01, Vol.121 (1), p.185-193

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of 1p19q status and Ki67 index to predict extent of resection in WHO grade II gliomas: a virtual patient model

Journal of neuro-oncology, 2015-06, Vol.123 (2), p.317-318

2015

Link zum Volltext

Verfügbarkeit prüfen

Improved Tumor Control and Absence of Late Neurotoxicity using Alpha (213Bi) as Compared to Beta (90Y) labelled-DOTA-Substance P for the Treatment of Low Grade Gliomas

Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S109-S109

2019

Link zum Volltext

Verfügbarkeit prüfen

Procedures performed during neurosurgery residency in Europe

Acta neurochirurgica, 2020-10, Vol.162 (10), p.2303-2311

2020

Link zum Volltext

Verfügbarkeit prüfen

sigma up 90 Xi -DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

The Journal of nuclear medicine (1978), 2015-11, Vol.56 (11), p.1748-1748

2015

Link zum Volltext

Verfügbarkeit prüfen

90 Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

Journal of Nuclear Medicine, 2015-11, Vol.56 (11), p.1748-1751

2015

Link zum Volltext

Verfügbarkeit prüfen

sup 90^Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

The Journal of nuclear medicine (1978), 2015-11, Vol.56 (11), p.1748

2015

Link zum Volltext

Verfügbarkeit prüfen

Improved Tumor Control and Absence of Late Neurotoxicity using Alpha (213Bi) as Compared to Beta (90Y) labelled-DOTA-Substance P for the Treatment of Low Grade Gliomas

Journal of medical imaging and radiation sciences, 2019-03, Vol.50 (1), p.S37-S37

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

Effects of two types of exercise training on psychological well‐being, sleep, quality of life and physical fitness in patients with high‐grade glioma (WHO III and IV): study protocol for a randomized controlled trial

Targeted Radiolabeled Compounds in Glioma Therapy

High Precision Bone Cutting by Er: YAG Lasers Might Minimize the Invasiveness of Navigated Brain Biopsies

Training of Denoising Diffusion Models for Prediction of real-time Growth of Primary and Recurrent Gliomas

Among Persons With Multiple Sclerosis (MS), Objective Sleep, Psychological Functioning, and Higher Physical Activity Scores Remained Stable Over 2 Years-Results From a Small Study Under Naturalistic Conditions

Association between IL-8 (-251T/A) and IL-6 (-174G/C) Polymorphisms and Oral Cancer Susceptibility: A Systematic Review and Meta-Analysis

90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

Local Targeting of Malignant Gliomas by the Diffusible Peptidic Vector 1,4,7,10-Tetraazacyclododecane-1-Glutaric Acid-4,7,10-Triacetic Acid-Substance P

Long-Term Results of Targeted Low-Grade Glioma Treatment with 213 Bi-DOTA-[Thi 8 ,Met(O 2 ) 11 ]-Substance P

Non-invasive neural stem cells become invasive in vitro by combinatorial FGF2 and BMP4 signaling

An Unusual Bump on the Head: Intracranial and Extracranial Cytokeratin-Positive Interstitial Reticular Cell Tumor

Effects of two types of exercise training on psychological well-being, sleep and physical fitness in patients with high-grade glioma (WHO III and IV)

Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study

Long-Term Tumor Control Following Targeted Alpha Therapy : A New Treatment Paradigm?

Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia

Anti-GABA A receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia

A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers

Influence of 1p19q status and Ki67 index to predict extent of resection in WHO grade II gliomas: a virtual patient model

Improved Tumor Control and Absence of Late Neurotoxicity using Alpha (213Bi) as Compared to Beta (90Y) labelled-DOTA-Substance P for the Treatment of Low Grade Gliomas

Procedures performed during neurosurgery residency in Europe

sigma up 90 Xi -DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

90 Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

sup 90^Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

Improved Tumor Control and Absence of Late Neurotoxicity using Alpha (213Bi) as Compared to Beta (90Y) labelled-DOTA-Substance P for the Treatment of Low Grade Gliomas

Suchergebnisse filtern